ADPT Sale Disclosure
Robins Harlan S · SEC Form 4 · Filed Jul 7, 2026
Sale
Calculated transaction value
$3.3M
Robins Harlan S Chief Scientific Officer
Transaction date
Jul 2, 2026
Public filing date
Jul 7, 2026
Filing lag
Filed 5 days later
ADPT daily price context
Close on/before transaction
$21.19
Jul 2, 2026
Close before public filing
$21.5
Jul 6, 2026
Return since public filing
+20.88%
Through Aug 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 146,889 shares @ $22.45
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780851-26-000015
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$8.5M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Sale | Jul 2, 2026 | $5.2M |
| Adaptive Biotechnologies Corp ADPT Current | Sale | Jul 2, 2026 | $3.3M |